DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for ankyloglossia — screening already-approved drugs against its 2-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleAnkyloglossia maps to a 2-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for ankyloglossia is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
Molecular view
T-box transcription factor 3 (TBX3) — TBX3 is one of the genes genetically linked to this disease in Open Targets — shown as context, not as a drug target we're pursuing: no approved-drug candidate for this disease is yet corroborated in the literature we found.
Loading structure…
helix sheet apo structuredrag to rotate · scroll to zoom
RCSB Protein Data Bank · entry 1H6F · 1.7 Å · ligand none (apo structure). Experimental structure, not a prediction.
What the evidence adds up to
A 2014 case series of children with ankyloglossia reported that all surgical techniques used — frenotomy and frenectomy with one or two hemostats, a groove director, or laser — were successful, provided a skilled professional performed them. The authors stated that laser may reduce the amount of local anaesthetic needed, bleeding, and the chances of infection, swelling, and discomfort. No sample size or quantitative outcomes were given for any technique.
A 1993 study of 38 adults with congenital ankyloglossia and deviation of the epiglottis and larynx found that 50 percent had obstructive respiratory failure. Vital capacity increased significantly after surgery, but changes in forced expiratory volume in one second were not prominent. Subjective symptoms — shoulder stiffness, cold extremities, throat obstruction, insomnia, fatigue, dry skin, irritability, anxiety, nervousness — improved postoperatively. Objective symptoms including snoring, muscle cramps, difficulty playing wind instruments, and hoarseness also improved, but incorrect articulation did not.
Two single-case reports describe alternative surgical methods. A 2016 report on a 21-year-old man treated with coblation radiofrequency surgery presented no outcome data beyond stating the method provides low-temperature work with minimal tissue damage. A 2015 report of one case treated with a diode laser noted marked improvement in tongue movement at follow-up, with uneventful healing.
All reports are small case series or single cases, none are controlled trials. No study compared surgical techniques against no treatment or sham surgery. There is no evidence from randomised trials to support any specific surgical method over another, and no data on long-term functional outcomes such as breastfeeding success in infants or speech development. What is missing is adequately powered randomised trials with blinded outcome assessment, standardised measures of tongue mobility and function, and long-term follow-up.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
Journal of Applied Oral Science · 2014 · 86 citations · open access
Surgical techniques for the treatment of ankyloglossia in children: a case series
AbstractThis paper reports a series of clinical cases of ankyloglossia in children, which were approached by different techniques: frenotomy and frenectomy with the use of one hemostat, two hemostats, a groove director or laser. Information on the indications, contraindications, advantages and disadvantages of the techniques was also presented. Children diagnosed with ankyloglossia were subjected to different surgical procedures. The choice of the techniques was based on the age of the patient, length of the frenulum and availability of the instruments and equipment. All the techniques presented are successful for the treatment of ankyloglossia and require a skilled professional. Laser may be considered a simple and safe alternative for children while reducing the amount of local anesthetics needed, the bleeding and the chances of infection, swelling and discomfort.
Congenital Ankyloglossia with Deviation of the Epiglottis and Larynx: Symptoms and Respiratory Function in Adults
AbstractWe operated on 38 adult patients with congenital ankyloglossia with deviation of the epiglottis and larynx. The results were as follows. 1) Most patients had Angle's class III malocclusion, irregular alignment of the upper teeth, and high hard palate. 2) Fifty percent of the patients in our study population had obstructive respiratory failure. Their vital capacity increased significantly after the operation, but changes of forced expiratory volume in 1 second were not prominent. 3) Subjective symptoms of this disease were stiffness of the shoulders, a cold feeling in the extremities, an obstructed feeling in the throat, insomnia, fatigue, dry skin, irritability and/or anxiety, and nervousness. These improved postoperatively. 4) Objective symptoms included snoring, muscle cramps, difficulty in playing wind instruments, hoarseness, and incorrect articulation. The objective symptoms, except for incorrect articulation, improved postoperatively.
Archives of Otolaryngology & Rhinology · 2016 · 2 citations · open access
Treatment of Ankyloglosia with Coblation Assisted Surgery
AbstractAnkyloglossia is a disease characterized by difficulty in breast-feeding, limitation of tongue, and speech disorders. Prevalence of the disease is %1-10 in the literature (1). Cold knife, Laser surgery, electro cautery methods are used in the surgical treatment of the disease. Coblation radiofrequency technology provides low temperature work with minimal damage to neighborhood tissues. We present a 21 years old male with ankyloglossia treated by coblation surgery in the lights of the literature.
Diode laser: An alternative treatment modality for ankyloglossia
AbstractAnkyloglossia or tongue-tie refers to an abnormally short lingual frenulum. Ankyloglossia is a recognized but poorly defined condition and has been reported to cause feeding difficulties, dysarthria, dyspnea, and social or mechanical problems in childhood and adolescence. This article reports a simple, safe, and effective way for management of ankyloglossia associated with restricted movement of the tongue. The treatment involved a diode laser for removal of the lingual frenum, which healed uneventfully. A marked improvement in the movement of the tongue was observed at follow-up visits in the treated case.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
